关注
Michael Brilhante, PhD
Michael Brilhante, PhD
Institute of Veterinary Bacteriology
在 vetsuisse.unibe.ch 的电子邮件经过验证
标题
引用次数
引用次数
年份
Shedding of OXA-181 carbapenemase-producing Escherichia coli from companion animals after hospitalisation in Switzerland: an outbreak in 2018
A Nigg, M Brilhante, V Dazio, M Clément, A Collaud, SG Brawand, B Willi, ...
Eurosurveillance 24 (39), 1900071, 2019
572019
Two decades of blaVIM-2-producing Pseudomonas aeruginosa dissemination: an interplay between mobile genetic elements and successful clones
J Botelho, F Grosso, S Quinteira, M Brilhante, H Ramos, L Peixe
Journal of Antimicrobial Chemotherapy 73 (4), 873-882, 2018
402018
Poor infection prevention and control standards are associated with environmental contamination with carbapenemase-producing Enterobacterales and other …
JS Schmidt, SP Kuster, A Nigg, V Dazio, M Brilhante, H Rohrbach, ...
Antimicrobial Resistance & Infection Control 9, 1-13, 2020
392020
Multidrug resistance and multivirulence plasmids in enterotoxigenic and hybrid Shiga toxin-producing/enterotoxigenic Escherichia coli isolated from diarrheic pigs in Switzerland
M Brilhante, V Perreten, V Donà
The Veterinary Journal 244, 60-68, 2019
362019
Employees of Swiss veterinary clinics colonized with epidemic clones of carbapenemase-producing Escherichia coli
A Endimiani, M Brilhante, OJ Bernasconi, V Perreten, JS Schmidt, V Dazio, ...
Journal of Antimicrobial Chemotherapy 75 (3), 766-768, 2020
312020
Evaluation of the recently launched rapid carb blue kit for detection of carbapenemase-producing gram-negative bacteria
 Novais, M Brilhante, J Pires, L Peixe
Journal of clinical microbiology 53 (9), 3105-3107, 2015
272015
OXA-181-producing extraintestinal pathogenic Escherichia coli sequence type 410 isolated from a dog in Portugal
M Brilhante, J Menezes, A Belas, C Feudi, S Schwarz, C Pomba, ...
Antimicrobial agents and chemotherapy 64 (4), 10.1128/aac. 02298-19, 2020
232020
Acquisition and carriage of multidrug‐resistant organisms in dogs and cats presented to small animal practices and clinics in Switzerland
V Dazio, A Nigg, JS Schmidt, M Brilhante, N Mauri, SP Kuster, ...
Journal of veterinary internal medicine 35 (2), 970-979, 2021
222021
A Novel Trimethoprim Resistance Gene, dfrA36, Characterized from Escherichia coli from Calves
D Wüthrich, M Brilhante, A Hausherr, J Becker, M Meylan, V Perreten
Msphere 4 (3), 10.1128/msphere. 00255-19, 2019
222019
Two high-risk clones of carbapenemase-producing Klebsiella pneumoniae that cause infections in pets and are present in the environment of a veterinary referral …
M Brilhante, S Gobeli Brawand, A Endimiani, H Rohrbach, S Kittl, B Willi, ...
Journal of Antimicrobial Chemotherapy 76 (5), 1140-1149, 2021
212021
Duration of carriage of multidrug-resistant bacteria in dogs and cats in veterinary care and co-carriage with their owners
V Dazio, A Nigg, JS Schmidt, M Brilhante, EI Campos-Madueno, N Mauri, ...
One Health 13, 100322, 2021
182021
PFM-like enzymes are a novel family of subclass B2 metallo-β-lactamases from Pseudomonas synxantha belonging to the Pseudomonas fluorescens complex
L Poirel, M Palmieri, M Brilhante, A Masseron, V Perreten, P Nordmann
Antimicrobial agents and chemotherapy 64 (2), 10.1128/aac. 01700-19, 2020
172020
Characterization of Third-Generation Cephalosporin-Resistant Escherichia coli Isolated from Pigs in Cuba Using Next-Generation Sequencing
RE Hernández-Fillor, M Brilhante, CM Marrero-Moreno, M Baez, ...
Microbial Drug Resistance 27 (7), 1003-1010, 2021
112021
Complete circular genome sequence of a multidrug-resistant Escherichia coli strain from Cuba obtained with Nanopore and Illumina hybrid assembly
RE Hernández-Fillor, M Brilhante, I Espinosa, V Perreten
Microbiology resource announcements 8 (48), 10.1128/mra. 01269-19, 2019
82019
A novel trimethoprim resistance gene, dfrA36, characterized from Escherichia coli from calves. mSphere 4: e00255-19
D Wüthrich, M Brilhante, A Hausherr, J Becker, M Meylan, V Perreten
52019
Characterisation of a porcine Escherichia coli strain from Switzerland carrying mcr-1 on a conjugative multidrug resistance IncHI2 plasmid.
M Brilhante, V Donà, G Overesch, A Endimiani, V Perreten
Journal of global antimicrobial resistance 16, 123-124, 2018
52018
Bacteriocin dynamics in Enterococcus faecium and Enterococcus lactis: implications for clinical and commensal strain interactions
AC Almeida-Santos, AP Tedim, B Duarte, M Brilhante, TM Coque, ...
Scientific Letters 1 (Sup 1), 2024
2024
Correction for Wüthrich et al.
D Wüthrich, M Brilhante, A Hausherr, J Becker, M Meylan, V Perreten
mSphere, 2019
2019
Relatórios de Estágio realizado na Farmácia Ferreira de Sousa e no Centro Hospitalar de Vila Nova de Gaia/Espinho, EPE
MQ Brilhante
2015
Unveiling clones and integrons dynamics associated with carbapenemase-producing P. aeruginosa clinical isolates in a Portuguese hospital
J Botelho, F Grosso, CCS Sousa, M Brilhante, C Rocha, L Peixe
2015
系统目前无法执行此操作,请稍后再试。
文章 1–20